← All stories
Markets
‘Game-changer’ GLP-1s could fix America’s obesity crisis—but 2 inequalities stand in the way
Wells Fargo Industry Insights' Robin Wenzel says the drugs are rewriting healthcare economics, but the math doesn't "pencil out" too often.
Covered by 1 outlet
All coverage · 1 article